Genetic background shapes AI-predicted variant effects

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-15

This study introduces pVEP, a framework that quantifies how genetic background across diverse human genomes influences computational predictions of clinical variant effects, revealing that some variants have heterogeneous predicted impacts depending on the genetic context.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-15 · read from full text

The study develops a personalized variant effect predictor (pVEP) to quantify how genetic background across thousands of globally diverse human genomes changes computational predictions of variant effects. Using deep learning models covering protein structure, splicing, and noncoding regulation, the authors report that many clinical variants show heterogeneous predicted effects across haplotypes, sometimes switching between pathogenic and benign predictions depending on background. They provide evidence for molecular mechanisms such as altered predicted protein contacts and differences in splice-site recognition. The paper’s main limitation is that its conclusions are based on AI-predicted effects rather than direct experimental validation across haplotypes. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

ABSTRACT Predicting the consequences of genetic variants remains a major goal in biomedicine. Conventional approaches typically assess single-nucleotide variants in the context of a single reference genome, without accounting for genetic diversity that can modulate variant effects. Here we introduce the personalized variant effect predictor (pVEP) framework, which quantifies how genetic background across thousands of human genomes from globally diverse populations shapes computational predictions of clinical variant effects. Across deep learning models spanning protein structure, splicing, and noncoding regulation, pVEP reveals that many clinical variants exhibit heterogeneous predicted effects across haplotypes, with the same variant predicted to be pathogenic in some genetic backgrounds and benign in others. We find support for underlying molecular mechanisms, including shifts in predicted protein contacts and changes in splice-site recognition. Overall, personalized genomic context emerges as a systematically underappreciated variable in variant annotation and clinical interpretation, with particular implications for genetically diverse populations.
Full text 1,441 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT Predicting the consequences of genetic variants remains a major goal in biomedicine. Conventional approaches typically assess single-nucleotide variants in the context of a single reference genome, without accounting for genetic diversity that can modulate variant effects. Here we introduce the personalized variant effect predictor (pVEP) framework, which quantifies how genetic background across thousands of human genomes from globally diverse populations shapes computational predictions of clinical variant effects. Across deep learning models spanning protein structure, splicing, and noncoding regulation, pVEP reveals that many clinical variants exhibit heterogeneous predicted effects across haplotypes, with the same variant predicted to be pathogenic in some genetic backgrounds and benign in others. We find support for underlying molecular mechanisms, including shifts in predicted protein contacts and changes in splice-site recognition. Overall, personalized genomic context emerges as a systematically underappreciated variable in variant annotation and clinical interpretation, with particular implications for genetically diverse populations. Competing Interest Statement The authors have declared no competing interest. Footnotes ↵* juannanzhou{at}ufl.edu and koo{at}cshl.edu https://ngs.sanger.ac.uk/production/hgdp/hgdp_wgs.20190516/statphase/ https://ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh38/clinvar.vcf.gz

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00